Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $540.94 | 7 | 95.2% |
| Education | $27.16 | 2 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $244.23 | 4 | $0 (2023) |
| TG Therapeutics, Inc. | $121.34 | 1 | $0 (2024) |
| ORGANOGENESIS INC. | $105.83 | 1 | $0 (2021) |
| Amarin Pharma Inc. | $65.62 | 1 | $0 (2019) |
| Siemens Medical Solutions USA, Inc. | $15.87 | 1 | $0 (2021) |
| EKOS Corporation | $15.21 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.34 | 1 | TG Therapeutics, Inc. ($121.34) |
| 2023 | $95.23 | 1 | Alexion Pharmaceuticals, Inc. ($95.23) |
| 2022 | $149.00 | 3 | Alexion Pharmaceuticals, Inc. ($149.00) |
| 2021 | $121.70 | 2 | ORGANOGENESIS INC. ($105.83) |
| 2019 | $80.83 | 2 | Amarin Pharma Inc. ($65.62) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $121.34 | General |
| Category: Immunology | ||||||
| 02/01/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $95.23 | General |
| Category: Rare Disease | ||||||
| 09/15/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Rare Disease | ||||||
| 09/01/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $26.16 | General |
| Category: Rare Disease | ||||||
| 09/01/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $1.00 | General |
| Category: Rare Disease | ||||||
| 05/19/2021 | Siemens Medical Solutions USA, Inc. | Atellica IM 1300 Analyzer (Device) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: DX - Diagnostics incl. all products and services | ||||||
| 03/25/2021 | ORGANOGENESIS INC. | Puraply Antimicrobial (Medical Supply) | Food and Beverage | Cash or cash equivalent | $105.83 | General |
| Category: Wound Care | ||||||
| 10/05/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $65.62 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/28/2019 | EKOS Corporation | EKOSONIC (Device) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: PERIPHERAL VASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 170 | 377 | $59,878 | $27,285 |
| 2022 | 6 | 227 | 540 | $83,403 | $36,708 |
| 2021 | 6 | 253 | 593 | $92,389 | $41,339 |
| 2020 | 5 | 288 | 566 | $90,982 | $41,129 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 260 | $32,760 | $15,894 | 48.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 40 | $14,040 | $5,466 | 38.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 46 | 48 | $8,880 | $4,091 | 46.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,094 | $1,231 | 39.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 16 | $1,104 | $602.90 | 54.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 361 | $45,486 | $20,080 | 44.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 48 | $16,848 | $7,436 | 44.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 59 | 63 | $11,655 | $5,139 | 44.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $4,284 | $1,788 | 41.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 15 | $2,715 | $1,201 | 44.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 23 | 35 | $2,415 | $1,065 | 44.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 75 | 390 | $49,140 | $21,956 | 44.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 51 | 53 | $18,603 | $8,375 | 45.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 66 | 69 | $12,765 | $5,762 | 45.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 20 | $4,760 | $2,149 | 45.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 26 | $4,706 | $2,037 | 43.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 23 | 35 | $2,415 | $1,061 | 43.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 79 | 330 | $41,580 | $19,042 | 45.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 64 | 67 | $23,517 | $10,669 | 45.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 74 | 76 | $14,060 | $6,385 | 45.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 32 | 32 | $7,616 | $3,147 | 41.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 39 | 61 | $4,209 | $1,886 | 44.8% |
About Dr. Mary Sementi, D.O
Dr. Mary Sementi, D.O is a Internal Medicine healthcare provider based in Waimea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770653966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Sementi, D.O has received a total of $568.10 in payments from pharmaceutical and medical device companies, with $121.34 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($540.94).
As a Medicare-enrolled provider, Sementi has provided services to 938 Medicare beneficiaries, totaling 2,076 services with total Medicare billing of $146,461. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Waimea, HI
- Active Since 11/08/2006
- Last Updated 11/05/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770653966
Products in Payments
- ULTOMIRIS (Biological) $149.00
- BRIUMVI (Drug) $121.34
- Puraply Antimicrobial (Medical Supply) $105.83
- SOLIRIS (Biological) $95.23
- Vascepa (Drug) $65.62
- Atellica IM 1300 Analyzer (Device) $15.87
- EKOSONIC (Device) $15.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.